|24th February 2021||Joshua Silverman||42,000||Grant/award etc.||$0.00|
|1st February 2021||Billy Joe White||45,440||Payment by withholding||$12.04||$547,097.60|
|1st February 2021||Billy Joe White||29,140||Exercise of derivative||$1.01||$29,431.40|
|8th December 2020||Bay Capital Management Lp Hudson||710,000||Other acquisition or disposition||$10.88||$7,724,800.00|
|7th December 2020||Bay Capital Management Lp Hudson||50,000||Open or private sale||$11.51||$575,500.00|
|1st December 2020||Joshua Silverman||20,000||Grant/award etc.||$0.00|
|1st December 2020||Joshua Silverman||100,000||Sale back to the issuer||$0.00|
|2nd November 2020||Bay Capital Management Lp Hudson||50,000||Open or private sale||$10.87||$543,500.00|
|16th October 2020||Joshua Silverman||50,000||Open or private purchase||$1.09||$54,445.00|
|16th October 2020||Bay Capital Management Lp Hudson||1,601,100||Other acquisition or disposition||$10.30||$16,491,330.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.
Akers Biosciences, Inc. develops health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products. The company was founded by Raymond Francis Akers, Jr. and Raymond F.Akers, Sr. on March 8, 1989.